Glaucoma is described, and the chemistry, pharmacology, pharmacokinetics, clinical
efficacy, adverse effects, and dosage and administration of betaxolol and levobunolol in …

Pulmonary functions, by means of FEV 1, FVC, and airway resistance, and cardiovascular
responses, ie, ECG, blood pressure, and pulse contour, were measured in 10 control and 15 …

This double-blind, randomised, within patient, placebo-controlled study set out to investigate
the effect of a cardioselective beta-blocker, atenolol, at different oral doses (50, 100 and 200 …

A randomized, double-blind, placebo-controlled clinical trial was designed to assess the
safety, efficacy, and duration of the bronchodilation resulting from the addition of 500 μg of …

It has been suggested that regular treatment with high doses of β2-agonists might result in
poorer control of asthma and increased bronchial responsiveness. We have examined …

1 The effects of atenolol (100 mg), a cardioselective beta‐adrenoceptor blocking agent, and
labetalol (300 mg), a combined alpha‐and non‐selective beta‐adrenoceptor blocking agent …

Objective To assess the impact of long-term treatment with topical timolol on bronchial
reactivity in healthy individuals. Methods Twenty-one otherwise healthy individuals with high …

The effects on respiratory function have been compared of five different beta-blocking drugs
injected intravenously in asthmatic patients. In all groups but one there was a decrease in …

A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with
non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was …

Thirty‐two eyes from 19 patients with either capsular glaucoma, pigmentary glaucoma or
primary open angle glaucoma were given topical timolol and followed through a 3–6 months …